Doctor profile · Federal record
Dr. CATHERINE ALBRECHT, FNP
Nurse Practitioner · Family Nurse Practitioner · NEW BRUNSWICK, NJ
- NPI 1710242623
- Accepts Medicare
- 27 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
125 PATERSON ST
NEW BRUNSWICK, NJ 089011962
(732) 235-7340 - Mailing address
-
147 N MAIN ST
MILLTOWN, NJ 088501523
Credentials & registration
- NPI registered
- July 2012 — 14 yrs on file
- Profile last updated
- February 19, 2026
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- New Jersey #26NN08265200
- Medicaid
- NJ #8367001
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1710242623. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
350
Distinct HCPCS
10
Medicare allowed
$27,909
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99203 |
New patient office or other outpatient visit, 30-44 minutes | 111 | 111 | $104 | |
96127 |
Assessment of emotional or behavioral problems | 43 | 41 | $5 | |
0241U |
Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | 37 | 37 | $140 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 37 | 37 | $146 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 31 | 28 | $85 | |
81003 |
Automated urinalysis test | 28 | 26 | $2 | |
87426 |
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 21 | 21 | $33 | |
87804 |
Detection test by immunoassay with direct visual observation for influenza virus | 20 | 11 | $16 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 11 | 11 | $112 | |
U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 11 | 11 | $50 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 35. This provider delivers 10.0× the peer median.Open Payments
Industry payments received
All-time total
$17
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 1 | $16.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
315
Patients
211
Total drug cost
$63,762
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 43 | 27 | $755 |
| Doxycycline Hyclate | Generic | 39 | 39 | $401 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 27 | 17 | $434 |
| Methylprednisolone | Generic | 27 | 27 | $242 |
| Synthroid (Levothyroxine Sodium) | Brand | 19 | 12 | $2,078 |
| Azithromycin | Generic | 18 | 17 | $139 |
| Metformin Hcl | Generic | 18 | 12 | $446 |
| Trulicity (Dulaglutide) | Brand | 18 | 0 | $31,115 |
| Amoxicillin-Clavulanate Potass (Amoxicillin/Potassium Clav) | Brand | 17 | 17 | $164 |
| Atorvastatin Calcium | Generic | 17 | 0 | $186 |